Bauchi Governor Authorises The Use Of Chloroquine For Treatment Of COVID-19

The Governor of Bauchi State, Bala Mohammed, on Wednesday said he has authorised the use of chloroquine as a medication for the treatment of COVID-19. 

ABN TV reports that Mr Mohammed, who was the COVID-19 index case in the state, said he was treated with “chloroquine and Zithromax.”

The governor, who disclosed this while providing an update on COVID-19 in the state, at the Government House, Bauchi, said he would take responsibility for any consequences of approving such drugs.

“Our medical team is using their own ingenuity to use chloroquine and Zithromax to treat the patients, even though in some places, they said it is against the protocol,” he said.

“As the governor, I’m taking responsibility for that because I don’t want anyone to die.

Read Also: Enugu, Port-Harcourt Returnees Test Positive For COVID-19 In Bauchi

Addressing the health officials directly, Mr Mohammed said, “I have given you the directive that you must use something that I have used to get well, just as you have used for all other cases that got well.

“Rather than saying that something is harmful, we should not follow what the white people are saying by not taking anything and die.

“We are used to taking chloroquine in Nigeria. We are going to use them. We have taken responsibility and I have taken responsibility.

“Zithromax and chloroquine are not harmful to our body, our physiological system has adapted to it. If you are having a fever you take chloroquine.”

He said it was for the reason of using the said drugs that Bauchi has not recorded any death.

“Nobody is affected with any serious distress in Bauchi, even though now we are going to be tested with the 23 cases.”

Mr Mohammed’s statement on chloroquine adds to the global debate on the appropriateness of recommending the drug.

While the drug has been found to be effective in some cases in treating COVID-19, the World Health Organisation and other experts have warned that it has not undergone essential clinical trials to be recommended for treating the disease; and may have detrimental side effects.

President Donald Trump of the U.S. was criticised last month for recommending the use of the drug for the treatment of COVID-19 in the U.S.